Rare
lephants
Screener
Toggle theme
Kyverna Therapeutics, Inc.
KYTX
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
Shares Outstanding
Compare
←
5Y
10Y
MAX
→
Shares Outstanding
Chart
Table
Fiscal Year
Shares Outstanding
FY2023
38.4M
FY2024
38.3M
FY2025
44.3M
FY2026
60.4M
Download CSV
